Immunic Inc share price logo

Immunic Inc Share Price

NASDAQ: IMUX

Small Cap

$0.77

-0.02

(-2.79%)

as on

Immunic Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $0.75
    $0.83
    downward going graph

    2.60%

    Downside

    7.79%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.56
    $2.11
    downward going graph

    27.14%

    Downside

    174.03%

    Upside

    downward going graph

Immunic Inc share price movements today

Previous Close
$0.79
Open
$0.80
Volume
1.8M
Day's Low - High
$0.75 - $0.83
52 Week Low - High
$0.56 - $2.11

Immunic Inc Historical Returns

1 Month Return
-11.88 %
3 Month Return
-1.32 %
1 Year Return
-47.74 %
3 Year Return
-80.14 %
5 Year Return
-95.57 %

Immunic Inc Stock Fundamentals & Key Indicators

Check Immunic Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$78.4M

EPS (TTM)

-0.7083

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-105.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

51340300.00%

Immunic Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunic Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$78.4M-95.57%NA0.00%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Immunic Inc Stock including INR - Dollar returns

The Immunic Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immunic Inc investment value today

Current value as on today

₹55,643

Returns

₹44,357

(-44.36%)

Returns from Immunic Inc Stock

₹49,342 (-49.34%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Immunic Inc Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Immunic Inc. Average target price of $7.47

Immunic Inc Share Price Target

Get share price movements and forecasts by analysts on Immunic Inc.

What analysts predicted

89.69%UPSIDE

Target Price

$7.47

Current Price

$0.77

Analyzed by

11 Analysts

Target

$7.47

Immunic Inc target price $7.47, a slight upside of 89.69% compared to current price of $0.77. According to 11 analysts rating.

Immunic Inc Stock's Interest Amongst Investors

Search interest for Immunic Inc Stock has increased by 86% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:86% versus previous 30 day period

Immunic Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
0
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-27
-25
-23
-23
-23
-22
-25
-25
-26
-27
EBITDA
-27
-24
-23
-23
-23
-22
-25
-25
-26
-26
Interest Expense
2
-
-
2
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-25
-23
-22
-21
-29
-21
-24
-25
-25
-26
Income Tax Expense
-2
0
0
3
0
-
-
0
-
-
Net Income
-23
-23
-22
-21
-29
-21
-24
-25
-25
-26
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-22083.33%
0.00%
0.00%

Immunic Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
Operating Income
-41
-52
-42
-37
-48
-91
-119
-99
-98
EBITDA
-39
-51
-15
-36
-48
-91
-120
-99
-100
Interest Expense
-
-
-
0
0
0
1
-
-
Depreciation
-
0
0
0
0
0
0
0
0
Income Before Tax
-40
-52
-41
-34
-44
-92
-120
-93
-100
Income Tax Expense
-1
0
0
0
0
0
33
-
-100
Net Income
-40
-52
-41
-34
-43
-92
-120
-93
-100
Net Profit Margin
-682816.67%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Immunic Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-23
-22
-21
-29
-21
-24
-25
-25
-26
Operating Cash Flow
-19
-17
-14
-23
-17
-20
-22
-21
-24
Investing Cash Flow
4
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
0
74
-
-
0
-
65
Change in Cash
-15
-17
-13
50
-17
-20
-23
-21
41

Immunic Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-40
-52
-41
-34
-44
-92
-120
-93
-100
Operating Cash Flow
-35
-40
-43
-28
-46
-83
-65
-70
-84
Investing Cash Flow
0
0
0
10
0
0
-9
9
0
Financing Cash Flow
12
37
0
34
144
42
95
1
74
Change in Cash
-23
-3
-43
16
98
-40
19
-60
-11

Global Institutional Holdings in Immunic Inc

Funds
Holdings
Bvf Inc
9.29%
Aberdeen Group PLC
8.6%
Soleus Capital Management, L.P.
7.61%
Avidity Partners Management LP
4.65%
Vanguard Group Inc
4.1%

Insights on Immunic Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 196.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 122.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, IMUX stock has moved down by -9.8%

About Immunic Inc

immunic, inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases, including relapsing-remitting multiple sclerosis, ulcerative colitis, crohn's disease, and psoriasis. its lead development program is imu-838, a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme dihydroorotate dehydrogenase, which is in phase 2 clinical development for treatment of ulcerative colitis and relapsing-remitting multiple sclerosis, as well as in phase 2 trial to treat crohn's disease. the company is also developing imu-935, an inverse agonist of rorgt; and imu-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. immu
OrganisationImmunic Inc
Headquarters1200 Avenue of the Americas, New York, NY, United States, 10036
IndustryPharmaceuticals: Major
CEODr. Daniel Vitt Ph.D.
E-voting on sharesClick here to vote

Key Management of Immunic Inc

Name

Title

Mr. Glenn Whaley CPA

Chief Financial Officer

Ms. Jessica Breu

Head of Investor Relations & Communications

Mr. Patrick Walsh

Chief Business Officer

Dr. Andreas Muehler M.D., Ph.D.

Chief Medical Officer

Dr. Hella Kohlhof

Chief Scientific Officer

Mr. Inderpal Singh

General Counsel

Mr. Werner Gladdines

Chief Development Officer

Dr. Duane D. Nash J.D., M.B.A., M.D.

Executive Chairman

Dr. Daniel Vitt Ph.D.

CEO & Director

Mr. Jason Tardio M.B.A.

COO & President

FAQs

What is Immunic Inc share price today?

Immunic Inc share price today is $0.77 as on at the close of the market. Immunic Inc share today touched a day high of $0.83 and a low of $0.75.

What is the 52 week high and 52 week low for Immunic Inc share?

Immunic Inc share touched a 52 week high of $2.11 on and a 52 week low of $0.56 on . Immunic Inc stock price today i.e. is closed at $0.77,which is 63.51% down from its 52 week high and 37.25% up from its 52 week low.

What is Immunic Inc's market capitalisation today?

Immunic Inc market capitalisation is $0.00T as on .

How to invest in Immunic Inc Stock (IMUX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immunic Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunic Inc Shares that will get you 1.9481 shares as per Immunic Inc share price of $0.77 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Immunic Inc Stock (IMUX) from India?

Indian investors can start investing in Immunic Inc (IMUX) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Immunic Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Immunic Inc share’s latest price of $0.77 as on September 16, 2025 at 1:29 am IST, you will get 12.9870 shares of Immunic Inc. Learn more about fractional shares .

What are the returns that Immunic Inc has given to Indian investors in the last 5 years?

Immunic Inc stock has given -95.57% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?